MDCX (Medicus Pharma) Payments of Debt: $-10.58 Mil (TTM As of Mar. 2026)


MDCX Medicus Pharma Ltd MDCX
13 GF Score
Price $0.42
! 2 Warning Signs
View Full Analysis

What is Medicus Pharma Payments of Debt?

Medicus Pharma MDCX +4.07% 13 Payments of Debt is $-10.58 Mil as of Mar. 2026. GuruFocus rates MDCX with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Medicus Pharma's Payments of Debt for the three months ended in Mar. 2026 was $-3.19 Mil.

Medicus Pharma's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was $-10.58 Mil.

Medicus Pharma Payments of Debt Related Terms

Medicus Pharma Payments of Debt Historical Data

* Premium members only.

The historical data trend for Medicus Pharma's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicus Pharma Payments of Debt Chart

Medicus Pharma Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
0.00 0.00 0.00 0.00 -7.39

Medicus Pharma Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.06 -5.72 -1.62 -3.19
MDCX
13GF Score
Medicus Pharma Ltd MDCX
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicus Pharma Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.58 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of $-10.58 Mil mean?
Medicus Pharma (MDCX) has a Payments of Debt of $-10.58 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Medicus Pharma and its competitors.
Is Medicus Pharma's Payments of Debt too high?
Medicus Pharma's current Payments of Debt is $-10.58 Mil. Overall, Medicus Pharma has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Medicus Pharma's Payments of Debt compare to NSRX and MIRA?
Medicus Pharma's Payments of Debt of $-10.58 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Medicus Pharma and its competitors. Medicus Pharma's current Payments of Debt is $-10.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicus Pharma stock overvalued right now?
Medicus Pharma (MDCX) has a current Payments of Debt of $-10.58 Mil. The current Payments of Debt is $-10.58 Mil. Medicus Pharma's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Medicus Pharma (MDCX), the current Payments of Debt is $-10.58 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicus Pharma Business Description

Address 100 King Street West, Suite 3400, One First Canadian Place, Toronto, ON, CAN, M5X 1A4
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
13GF Score

Get the complete analysis for MDCX

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.42
Price